[Role of advanced practice nurse within a cellular therapy unit: Recommendations of the Francophone Society of Bone Marrow Transplantation and cellular therapy (SFGM-TC)].
Rôle de l’infirmière en pratique avancée (IPA) dans une unité de thérapie cellulaire : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC).
Advanced practice nurse
CAR T-cell therapy
CAR-T cells
Cellular therapy
Greffe hématopoïétique
Hematopoietic cell transplantation
Infirmière
Nurse practitioner
Pratique avancée
Thérapie cellulaire
Journal
Bulletin du cancer
ISSN: 1769-6917
Titre abrégé: Bull Cancer
Pays: France
ID NLM: 0072416
Informations de publication
Date de publication:
14 Feb 2023
14 Feb 2023
Historique:
received:
10
11
2022
revised:
03
01
2023
accepted:
09
01
2023
entrez:
16
2
2023
pubmed:
17
2
2023
medline:
17
2
2023
Statut:
aheadofprint
Résumé
Like the "nurse practitioner" in Anglo-Saxon countries, the French health authority validated on January 2016 the creation of an intermediate grade called advanced practice nurse (APN). They are authorized to carry out an assessment of the person's state of health, through a complete clinical examination. They can also prescribe additional examinations necessary for the monitoring of the pathology, and carry out certain acts for diagnostic and/or therapeutic purposes. Given the specificities of cellular therapy patients, the content of university professional training doesn't seem sufficient to assure an optimal management by the APN of these patients. The Francophone society of bone marrow transplantation and cellular therapy (SFGM-TC) had already published two works regarding what was initially called "the transfer of skills" between doctors and nurses in the follow-up of transplant patients. In the same way, this workshop attempts to address the question of the place of APNs in the management of patients undergoing cellular therapy treatment. Beyond a delegation of tasks as proposed by the cooperation protocols, this workshop produces recommendations to allow an autonomous activity of the IPA in the follow-up of these patients, in close collaboration with the medical team.
Identifiants
pubmed: 36797127
pii: S0007-4551(23)00051-6
doi: 10.1016/j.bulcan.2023.01.010
pii:
doi:
Types de publication
English Abstract
Practice Guideline
Langues
fre
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2023 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.